Carregant...
P19. Overall survival in advanced lung cancer patients proposed to receive initial chemotherapy according to actual chemotherapy delivery
BACKGROUND: The benefits of chemotherapy in advanced lung cancer patients are well known. However, after evaluating patient eligibility, not all patients proposed for chemotherapy by multidisciplinary tumour board (MTB) actually receive it. In routine clinical practice, it is important to review the...
Guardat en:
| Publicat a: | Transl Lung Cancer Res |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Pioneer Bioscience Publishing Company
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4367757/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2218-6751.2014.AB031 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|